Compare · CTSH vs MDRX
CTSH vs MDRX
Side-by-side comparison of Cognizant Technology Solutions Corporation (CTSH) and Veradigm Inc. (MDRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CTSH and MDRX operate in EDP Services (Technology), so they compete in similar markets.
- CTSH is the larger of the two at $28.41B, about 11.3x MDRX ($2.52B).
- CTSH has been more active in the news (3 items in the past 4 weeks vs 1 for MDRX).
- CTSH has more recent analyst coverage (25 ratings vs 17 for MDRX).
- Company
- Cognizant Technology Solutions Corporation
- Veradigm Inc.
- Price
- -
- -
- Market cap
- $28.41B
- $2.52B
- 1M return
- +34.06%
- -
- 1Y return
- -12.02%
- -
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1998
- News (4w)
- 3
- 1
- Recent ratings
- 25
- 17
Cognizant Technology Solutions Corporation
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. The company operates through four segments: Financial Services; Healthcare; Products and Resources; and Communications, Media and Technology. It offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; and enhanced compliance, integrated health management, claims investigative services, and patient experience, as well as services that drive operational improvements in areas, such as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. The company also provides solution to manufacturers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and cloud, interactive, and IoT services to information, media and entertainment, and communications and technology companies. Cognizant Technology Solutions Corporation was founded in 1994 and is headquartered in Teaneck, New Jersey.
Veradigm Inc.
Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates in two segments: The Core Clinical and Financial Solutions; and The Data, Analytics and Care Coordination. The Core Clinical and Financial Solutions segment provides software applications for patient engagement, and integrated clinical and financial management solutions, which primarily include EHR-related software; and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Data, Analytics and Care Coordination segment offers practice reimbursement, and payer and life sciences solutions, which are primarily targeted at physician practices, payers, life sciences companies, and other healthcare stakeholders. Its solutions enable clients to transition, analyze, and coordinate care and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Latest CTSH
- Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin's R&D
- CLO, CAO & Corporate Secretary Kim John Sunshin sold $142,625 worth of shares (2,500 units at $57.05) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 40,392 units (SEC Form 4)
- Chief Financial Officer Dalal Jatin P sold $669,168 worth of shares (12,000 units at $55.76) as part of a pre-agreed trading plan, decreasing direct ownership by 21% to 46,111 units (SEC Form 4)
- SEC Form 10-Q filed by Cognizant Technology Solutions Corporation
- Cognizant Technology Solutions Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Cognizant Reports Second Quarter 2026 Results
- Cognizant launches EMEA AI Unit to help enterprises scale agentic AI adoption
- The Andover Companies Selects Cognizant to Modernize Technology and Advance AI-Driven Innovation
- Cognizant and Anthropic expand partnership to embed Claude in Cognizant's industry platforms, helping clients close the gap between AI promise and business outcomes
- Cognizant and Gulf Edge Announce Strategic Partnership to Accelerate Enterprise AI Adoption in Southeast Asia
Latest MDRX
- Veradigm to Participate in Two Upcoming Investor Conferences
- Veradigm to Release Business Update May 26th and Host Investor Call May 27th
- Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices
- Veradigm Receives KLAS 2026 Points of Light Award for Embedding SDOH Data in Provider EHR Workflows
- Veradigm Doubles India-Based Employee Footprint, Adds New Managing Director
- Veradigm Appoints Christian Greyenbuhl as Chief Financial Officer
- Veradigm Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13G/A filed by Veradigm Inc.
- Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution
- Veradigm to Release Business Update February 17th and Host Investor Call February 18th